Jason Yuan

Jason (Zheng) Yuan has extensive work experience in the pharmaceutical industry, with a focus on biostatistics in oncology and rare diseases. Jason (Zheng) most recently served as the VP of Biometrics at Neumora since March 2022. Prior to that, they worked as a Director of Biostatistics at Vertex Pharmaceuticals from July 2016 to February 2022. Additionally, Jason held positions as an Associate Director/Director of Biostatistics at Agios Pharmaceuticals from January 2015 to July 2016 and as a Senior Principal Statistician - Oncology at Takeda Oncology from August 2012 to January 2015. Jason (Zheng) started their career at Eli Lilly and Company as a Research Scientist - Oncology from November 2006 to July 2012.

Jason (Zheng) Yuan completed their Bachelor's Degree in an unspecified field of study at the University of Science and Technology of China from 1996 to 2000. Jason (Zheng) then pursued a Master of Science (M.S.) degree in Statistics from Iowa State University from 2000 to 2002. Following that, they earned a Doctor of Philosophy (Ph.D.) degree in Biostatistics from the University of Michigan, where they studied from 2002 to 2006.